[Sodium cromoglycate eyewash in allergic conjunctivitis. Multicentric controlled double-blind study. Review of the literature].
A randomized double-blind trial was conducted in 143 out-patients with allergic conjunctivitis (281 eyes). Active sodium cromoglycate collyre was compared with placebo in parallel groups over a four-week period. Highly significant advantage for active drug was demonstrated for subjective and objective symptoms as well as for overall assessment by patients and physicians. Results were compared with international data concerning this well-known anti-allergic compound.
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011897:Random Allocation
D009883:Ophthalmic Solutions; D004205:Cromolyn Sodium
Cromoglycate de sodium en collyre dans les conjonctivites allergiques. Etude contrôlée multicentrique à double insu. Revue de la littérature.